| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $333.8M | +26.1% |
| Cost of Revenue | $137.2M | +13.7% |
| Gross Profit | $196.6M | +36.4% |
| R&D Expense | $96.2M | +13.6% |
| SG&A Expense | $83.7M | +14.7% |
| Operating Income | -$44.6M | +29.9% |
| Pre-tax Income | -$40.5M | +35.5% |
| Income Tax | $308K | +600.0% |
| Net Income | -$40.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.4M | +130.6% |
| Accounts Receivable | $38.7M | +9.1% |
| Current Assets | $181.4M | +22.1% |
| Total Assets | $437.3M | +9.4% |
| Current Liabilities | $45.6M | +15.6% |
| Total Liabilities | $80.2M | +7.2% |
| Stockholders' Equity | $357.0M | +9.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.6M | +206.3% |
| Capital Expenditures | $1.2M | +12.9% |
| Investing Cash Flow | $23.0M | -32.1% |
| Financing Cash Flow | $11.8M | +113.4% |
| Free Cash Flow | $17.4M | +193.8% |
| +35.1% |
| EPS (Basic) | -$0.41 | +38.8% |
| EPS (Diluted) | -$0.41 | +38.8% |